For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
The National Prescribing Service Limited (NPS) has prepared a stakeholder consultation report in collaboration with Palliative Care Australia (PCA). The report summarises the current situation with respect to quality use of medicine (QUM) in palliative and end-of-life care and aims to guide the direction of future activities to improve this. It is an important first step in documenting the issues and opportunities around QUM in palliative care, and stakeholders should be encouraged to further expand this work, develop and progress relevant initiatives and strategies within their sectors and engage others to improve QUM in palliative care and end of life care.
In May 2009 the Federal Government announced it would fund NPS to help requestors improve their utilisation of diagnostic imaging and pathology testing. As part of this program, NPS held a workshop on 29 April 2010, bringing together stakeholders from key organisations to gain:
The report provides a summary of the outcomes from this workshop.
Date published: 2010-09-02 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.